Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
Despite a good initial response to chemotherapy, the majority of patients with epithelial ovarian cancer will eventually recur and die of their disease. The introduction of targeted therapies to traditional chemotherapy regimens has done little to improve overall survival in women with ovarian cance...
Saved in:
Main Authors: | Haller J. Smith (Author), J. Michael Straughn (Author), Donald J. Buchsbaum (Author), Rebecca C. Arend (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted therapy in high grade serous ovarian Cancer: A literature review
by: Kaitlyn Dinkins, et al.
Published: (2024) -
Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
by: Bo Dong, et al.
Published: (2020) -
EPITHELIAL OVARIAN CANCER. CLINICAL LECTURE
by: A. E. Solopova, et al.
Published: (2016) -
Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
by: Xu Huang, et al.
Published: (2023) -
Treatment for recurrent epithelial ovarian cancer
by: Yiu-Tai Li, et al.
Published: (2021)